Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FibroScan for Diagnosis of Elevated Central Venous Pressure in Heart Failure
NCT07222813Recruiting
- Sponsor
- Echosens
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 4
01
Overview
Open-label, single-arm trial, sponsored by Echosens. Primary endpoints: Sensitivity of LSM for elevated CVP at Day 0 and Specificity of LSM for elevated CVP at Day 0. Started Apr 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07222813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222813.